Skip to main content
. Author manuscript; available in PMC: 2017 Jan 1.
Published in final edited form as: Mov Disord Clin Pract. 2015 Sep 16;3(1):9–18. doi: 10.1002/mdc3.12225

Table 1.

Cognitive Outcome Measures

OUTCOME
MEASURE
REFERENCE
FOR
STUDIES
USED
DIAGNOSTIC
UTILITY
INTER-
RATER
RELIABILITY
TEST-
RETEST
RELIABILITY
RESPONSIVENESS CLINICALLY
MEANINGFUL
CHANGE
ENDORSEMENT
ADAS-cog 2527, 28, 33, 34, 37 & 38 Not Established High Moderate to high Yes 4 points Recommended
MDRS 23, 31, 32 & 38 High High High Yes Not established Recommended
MoCA Not used Moderate High High Yes Not established Suggested
CDR 25, 27 & 39 Not established Not established Moderate Yes Not established Suggested
FAB 33 & 34 Moderate High High Not established Not established Suggested
D-KEFS VF 2527, 34 & 37 Low to moderate Not established Moderate to high Not established Not established Suggested
HVLT 31 High Not established Not established Not established Not established Suggested
TPCT 23, 27 & 33 High Not established Not established Not established Not established Suggested
MMSE 2228, 3135, 37 & 38 Low to Moderate High High Low for small changes 1.4 points Listed
QTCS 22 Not established Not established Not established Not established Not established Listed
VMI 31 Not established Not established Not established Not established Not established Listed
BTA 26 & 31 Not established Not established Not established Not established Not established Listed
Endorsement definitions:
  1. “Recommended”: the outcome measure has been applied to PDD patients and has been found valid, reliable and responsive in psychometric studies in studies of PDD or other dementias
  2. “Suggested”: the outcome measure has been applied to PDD patients and psychometric studies are promising (“moderate” to “high” parameters), but not yet complete in dementia populations and/or some psychometric properties are suboptimal (“low”)
  3. “Listed”: the outcome measure has been applied to PDD patients but psychometric studies have demonstrated disappointing data (“low” parameters) and/or have not yet been performed in dementia populations

Abbreviations: MMSE: Mini-Mental Status Examination; ADAS-cog: Alzheimer’s Disease Assessment Scale – Cognitive Subscale; MDRS: Mattis Dementia Rating Scale; MoCA: Montreal Cognitive Assessment; CDR: Cognitive Drug Research system; FAB: Frontal Assessment Battery; D-KEFS VF: Delis-Kaplan Executive Function System Verbal Fluency test; TPCT: Ten Point Clock Drawing Test; QTCS: Quick Test of Cognitive Speed; HVLT: Hopkins Verbal Learning Test Revised; VMI: Developmental Test of Visual-Motor Integration; BTA: Brief Test of Attention